Trial Profile
A Randomized, Open-labeled, Comparative 3-way Crossover Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2013
Price :
$35
*
At a glance
- Drugs Pelubiprofen (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Daewon Pharmaceutical
- 05 Feb 2013 New trial record